Skip to Main content Skip to Navigation
Journal articles

Tamoxifen resistance and epigenetic modifications in breast cancer cell lines.

Abstract : Epigenetic mechanisms play crucial roles in many processes, including neoplasia, genomic imprinting, gene silencing, differentiation, embryogenesis and X chromosome inactivation. Their relevance in human disease and therapy has grown rapidly with the recent emergence of drugs that target for example DNA methylation or histone acetylation. Epigenetic effects were also recently highlighted by the deciphering of the mechanism of action of steroid hormones and anti-hormones acting through nuclear receptors. In this review, we focus on the epigenetic effects associated with long-term treatment of breast cancer cells with the antiestrogen (AE) tamoxifen, in the context of resistance appearance. We summarize the data obtained with a model cell line developed in our laboratory supporting a role for HP1 proteins in the irreversible inactivation of gene expression by long-term treatment with AE.
Document type :
Journal articles
Complete list of metadatas

Cited literature [4 references]  Display  Hide  Download

https://www.hal.inserm.fr/inserm-00230236
Contributor : Yves Le Ster <>
Submitted on : Tuesday, November 10, 2009 - 3:54:57 PM
Last modification on : Tuesday, November 24, 2020 - 9:12:03 AM
Long-term archiving on: : Monday, May 3, 2010 - 4:55:25 PM

Identifiers

  • HAL Id : inserm-00230236, version 1
  • PUBMED : 18220739

Collections

Citation

Eric Badia, Joan Oliva, Patrick Balaguer, Vincent Cavaillès. Tamoxifen resistance and epigenetic modifications in breast cancer cell lines.. Current Medicinal Chemistry, Bentham Science Publishers, 2007, 14 (28), pp.3035-45. ⟨inserm-00230236⟩

Share

Metrics

Record views

177

Files downloads

2325